These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Mast cells as a target in the treatment of rheumatoid arthritis. Bakharevski O; Ryan PF Inflammopharmacology; 1999; 7(4):351-62. PubMed ID: 17657438 [TBL] [Abstract][Full Text] [Related]
86. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Suri S; Gill SE; Massena de Camin S; Wilson D; McWilliams DF; Walsh DA Ann Rheum Dis; 2007 Nov; 66(11):1423-8. PubMed ID: 17446239 [TBL] [Abstract][Full Text] [Related]
87. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis. Grimsholm O; Rantapää-Dahlqvist S; Forsgren S Arthritis Res Ther; 2005; 7(3):R416-26. PubMed ID: 15899028 [TBL] [Abstract][Full Text] [Related]
88. Elevated nerve growth factor levels in the synovial fluid of patients with inflammatory joint disease. Halliday DA; Zettler C; Rush RA; Scicchitano R; McNeil JD Neurochem Res; 1998 Jun; 23(6):919-22. PubMed ID: 9572681 [TBL] [Abstract][Full Text] [Related]
89. Pathophysiology of joint pain. Kidd BL; Morris VH; Urban L Ann Rheum Dis; 1996 May; 55(5):276-83. PubMed ID: 8660099 [No Abstract] [Full Text] [Related]
90. Neurogenic inflammation and sensitivity to environmental chemicals. Meggs WJ Environ Health Perspect; 1993 Aug; 101(3):234-8. PubMed ID: 8404760 [TBL] [Abstract][Full Text] [Related]
91. Effect of three animal models of inflammation on nerve fibres in the synovium. Mapp PI; Walsh DA; Garrett NE; Kidd BL; Cruwys SC; Polak JM; Blake DR Ann Rheum Dis; 1994 Apr; 53(4):240-6. PubMed ID: 8203952 [TBL] [Abstract][Full Text] [Related]
93. Sympathetic nervous system in chronic joint pain. Veale DJ; Fitzgerald O Ann Rheum Dis; 1993 Jul; 52(7):552. PubMed ID: 7688501 [No Abstract] [Full Text] [Related]
94. Mechanoreceptor endings of the cervical, thoracic, and lumbar spine. McLain RF; Raiszadeh K Iowa Orthop J; 1995; 15():147-55. PubMed ID: 7634025 [No Abstract] [Full Text] [Related]
95. Neurogenic switching: a hypothesis for a mechanism for shifting the site of inflammation in allergy and chemical sensitivity. Meggs WJ Environ Health Perspect; 1995 Jan; 103(1):54-6. PubMed ID: 7628426 [TBL] [Abstract][Full Text] [Related]
96. Innervation of the synovium. Mapp PI Ann Rheum Dis; 1995 May; 54(5):398-403. PubMed ID: 7540827 [No Abstract] [Full Text] [Related]
97. Neurogenic influences in arthritis. Kidd BL; Mapp PI; Blake DR; Gibson SJ; Polak JM Ann Rheum Dis; 1990 Aug; 49(8):649-52. PubMed ID: 2204315 [No Abstract] [Full Text] [Related]
98. Time-dependent synergistic interactions between the vasodilator neuropeptide, calcitonin gene-related peptide (CGRP) and mediators of inflammation. Buckley TL; Brain SD; Rampart M; Williams TJ Br J Pharmacol; 1991 Jun; 103(2):1515-9. PubMed ID: 1884106 [TBL] [Abstract][Full Text] [Related]
99. Increased calcitonin gene-related peptide (CGRP), substance P, and enkephalin immunoreactivities in dorsal spinal cord and loss of CGRP-immunoreactive motoneurons in arthritic rats depend on intact peripheral nerve supply. Kar S; Gibson SJ; Rees RG; Jura WG; Brewerton DA; Polak JM J Mol Neurosci; 1991; 3(1):7-18. PubMed ID: 1715733 [TBL] [Abstract][Full Text] [Related]
100. Role of substance P in inflammatory arthritis. Garrett NE; Mapp PI; Cruwys SC; Kidd BL; Blake DR Ann Rheum Dis; 1992 Aug; 51(8):1014-8. PubMed ID: 1384440 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]